The GSH and NAC digestive degradation occurring during oral treatments lead to consider GSH and NAC nebulization as a viable alternative to manage early stages of COVID-19 disease (Santos Duarte Lana et al., 2021)
Both belong to a new generation of injectable peptide-based therapies that work by targeting multiple hormonal pathways simultaneously, offering potentially greater metabolic benefits than earlier single-receptor agents
Patients were treated with 16 weeks and magnetic resonance imaging (MRI)-proton density fat fraction [MRI-PDFF] and homeostasis model assessment of insulin resistance [HOMA-IR]) and homeostasis model assessment of insulin resistance (HOMA-IR) fibro-inflammation markers (alanine aminotransferase [ALT], corrected T1 [cT1], keratin-18 [K-18] M65, and N-terminal type III collagen pro-peptide [Pro-C3]) was applied
Heres how they work and who theyre for
Personalized peptide therapy may offer alternatives to traditional pharmaceuticals for issues such as chronic inflammation and post-surgical recovery when used with proper oversight
Danish Agency for Science and Higher Education grant 0237-00005B (S.R